Topiramate
NDC 68462-218, Topiramate, capsule, coated pellets, from Glenmark Pharmaceuticals Inc., USA.
- Product NDC
- 68462-218
- Status
- Listed
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Dosage form
- CAPSULE, COATED PELLETS
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217869
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68462-218 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOPIRAMATE15 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68462-218-60 | 68462021860 | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (68462-218-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/872927eb-0b61-44bb-9892-3c700b6f2181NADAC price for package 68462021860
GET /v1/drugs/nadac/68462021860
Use it
Look up 68462-218 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68462-218 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68462-218. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.